Insider Transactions Reported by 28 Insiders of Q32 Bio Inc.

Symbol
QTTB on Nasdaq
Location
Waltham, MA

Insiders trading volume in the past year

Q32 Bio Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
W. Bradford Smith Chief Financial and Business Officer and Treasurer $2,899,867 23 Feb 2023
Lee Kalowski CFO and President $2,327,216 -$57,067 -2.4% 25 Feb 2026
Michael L. Blum Chief Commercial Officer $1,415,233 23 Feb 2023
ORBIMED ADVISORS LLC Director, 10%+ Owner $1,286,681 25 Mar 2024
Jason Campagna Chief Medical Officer $1,221,995 24 Feb 2025
Atlas Venture Fund X, L.P. 10%+ Owner $1,194,801 25 Mar 2024
Jodie Pope Morrison CEO, Director $402,251 -$141,445 -26% 25 Feb 2026
Shelia M. Violette Chief Scientific Officer $393,428 -$18,093 -4.4% 25 Feb 2026
Timothy P. Kelly Chief Operating Officer $383,965 24 Feb 2022
Iwicki Mark T. Director $342,666 23 Oct 2025
Steven Gillis Director $308,660 14 Jun 2023
Matthew R. Patterson Director $308,660 14 Jun 2023
Jeffrey V Poulton Director $308,660 14 Jun 2023
Alise Reicin Director $308,660 14 Jun 2023
Richard J. Gregory Director $241,560 15 Jun 2022
Kush Parmar Director $241,560 15 Jun 2022
Arthur Tzianabos Director $171,333 23 Oct 2025
Mary Thistle Director $171,333 23 Oct 2025
Diyong Xu Director $171,333 23 Oct 2025
Albert Seymour President and Chief Executive Officer, Director $96,184 06 Sep 2023
Kathleen Laporte Director $63,998 15 Jan 2026
Sven Ante Lundberg Director $55,998 15 Jan 2026
David S. Grayzel Director $44,998 15 Jan 2026
Isaac Manke Director $35,254 23 Oct 2025
Gabriel Cohn Chief Medical Officer $11,506 01 Jan 2022
Julie Jordan Chief Medical Officer $4,243 03 Aug 2023
Paul Alloway Former President and Chief Operating Officer of Homology Medicines, Inc. $1,483 25 Mar 2024
Charles Michaud Jr. Former Vice President, Corporate Controller and Treasurer of Homology Medicines, Inc. $529 25 Mar 2024

Recent Insider Transactions by Companies or Individuals for Q32 Bio Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Lee Kalowski QTTB Common Stock Sale -10% $18,035 $4.51 -3,995 35,943 25 Feb 2026 Direct
Jodie Pope Morrison QTTB Common Stock Sale -10% $44,674 $4.51 -9,896 89,104 25 Feb 2026 Direct
Shelia M. Violette QTTB Common Stock Sale -4.82% $12,708 $4.51 -2,815 55,569 25 Feb 2026 Direct
David S. Grayzel QTTB Stock Option (Right to Buy) Award 16,363 16,363 15 Jan 2026 Direct
Sven Ante Lundberg QTTB Stock Option (Right to Buy) Award 20,363 20,363 15 Jan 2026 Direct
Kathleen Laporte QTTB Stock Option (Right to Buy) Award 23,272 23,272 15 Jan 2026 Direct
Jodie Pope Morrison QTTB Common Stock Sale -18.5% $77,871 $3.46 -22,506 99,000 02 Dec 2025 Direct
Lee Kalowski QTTB Common Stock Sale -18.5% $31,395 $3.46 -9,072 39,938 02 Dec 2025 Direct
Sven Ante Lundberg QTTB Stock Option (Right to Buy) Award 53,521 53,521 23 Oct 2025 Direct
Iwicki Mark T. QTTB Stock Option (Right to Buy) Award 53,521 53,521 23 Oct 2025 Direct
Isaac Manke QTTB Stock Option (Right to Buy) Award 53,521 53,521 23 Oct 2025 Direct
Diyong Xu QTTB Stock Option (Right to Buy) Award 53,521 53,521 23 Oct 2025 Direct
Mary Thistle QTTB Stock Option (Right to Buy) Award 53,521 53,521 23 Oct 2025 Direct
David S. Grayzel QTTB Stock Option (Right to Buy) Award 53,521 53,521 23 Oct 2025 Direct
Arthur Tzianabos QTTB Stock Option (Right to Buy) Award 53,521 53,521 23 Oct 2025 Direct
Kathleen Laporte QTTB Stock Option (Right to Buy) Award 53,521 53,521 23 Oct 2025 Direct
Jodie Pope Morrison QTTB Common Stock Sale -7.95% $18,900 $1.80 -10,494 121,506 26 Aug 2025 Direct
Shelia M. Violette QTTB Common Stock Sale -4.87% $5,385 $1.80 -2,990 58,384 26 Aug 2025 Direct
Lee Kalowski QTTB Common Stock Sale -7.96% $7,636 $1.80 -4,240 49,010 26 Aug 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.